Machine learning models can predictpotential DDIs based on drug properties, such as chemicalstructure, mechanism of action, and pharmacokinetic properties.These models help pharmaceutical companies and regulatoryagencies identify and prioritize DDIs for further investigationduring drug development and post-marketing surveillance.